Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Authors
Keywords
-
Journal
Diabetes & Metabolism Journal
Volume 47, Issue 5, Pages 612-629
Publisher
Korean Diabetes Association
Online
2023-09-27
DOI
10.4093/dmj.2023.0067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)
- (2023) Mai Seki et al. Clinical and Experimental Nephrology
- The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies
- (2022) Alexandros Hadjivasilis et al. Journal of Clinical Medicine
- Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
- (2022) Bai-Hui Zhang et al. Frontiers in Molecular Biosciences
- Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
- (2022) Sang Heon Suh et al. Nutrients
- Low-density lipoprotein particles in atherosclerosis
- (2022) Ya-Nan Qiao et al. Frontiers in Physiology
- Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
- (2022) Joon Ho Moon et al. Endocrinology and Metabolism
- Non-High-Density Lipoprotein Cholesterol and Progression of Chronic Kidney Disease: Results from the KNOW-CKD Study
- (2022) Sang Heon Suh et al. Nutrients
- Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study
- (2022) Sang Heon Suh et al. Frontiers in Nutrition
- Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD
- (2021) Chieh-Li Yen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inflammation Alters Relationship Between High‐Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW‐CKD
- (2021) Jae Young Kim et al. Journal of the American Heart Association
- Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
- (2021) Arjun Majithia et al. CIRCULATION
- Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
- (2021) Changhyun Lee et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans
- (2021) Melissa Soohoo et al. Journal of the American Heart Association
- 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2020) Francois Mach et al. RUSSIAN JOURNAL OF CARDIOLOGY
- Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
- (2020) Edward K Duran et al. CLINICAL CHEMISTRY
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis
- (2020) Xinyi Wang et al. PHARMACOLOGICAL RESEARCH
- Association Between Serum High‐Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW‐CKD
- (2019) Ki Heon Nam et al. Journal of the American Heart Association
- Statin therapy increases lipoprotein(a) levels
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Arterial Stiffness in the Heart Disease of CKD
- (2019) Luca Zanoli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
- (2019) David M. Charytan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes
- (2019) Ian H. de Boer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Apolipoprotein B Particles and Cardiovascular Disease
- (2019) Allan D. Sniderman et al. JAMA Cardiology
- The role of lipoprotein (a) in chronic kidney disease
- (2018) Jemma C. Hopewell et al. JOURNAL OF LIPID RESEARCH
- HDL in CKD—The Devil Is in the Detail
- (2018) Florian Kronenberg JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
- (2018) Benjamin C. Storey et al. KIDNEY INTERNATIONAL
- Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease
- (2018) Peter P. Toth et al. KIDNEY INTERNATIONAL
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism
- (2017) Hua Chen et al. JOURNAL OF PROTEOME RESEARCH
- Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
- (2016) Xiaole Su et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial
- (2016) Michel Farnier et al. ATHEROSCLEROSIS
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2016) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis
- (2016) Jan Borén et al. CURRENT OPINION IN LIPIDOLOGY
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
- (2016) Nans Florens et al. Toxins
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
- (2015) Dean J. Kereiakes et al. AMERICAN HEART JOURNAL
- Cholesterol Metabolism in CKD
- (2015) Allison B. Reiss et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
- (2015) John J.P. Kastelein et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial
- (2015) Christopher P. Cannon et al. EUROPEAN HEART JOURNAL
- Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial
- (2015) Harold Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Current therapies for lowering lipoprotein (a)
- (2015) Julian C. van Capelleveen et al. JOURNAL OF LIPID RESEARCH
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Efficacy and Safety of Alirocumab as Add-on Therapy in High-Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
- (2015) Jennifer G. Robinson et al. CLINICAL CARDIOLOGY
- Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance
- (2015) Andrea R. Zammit et al. PLoS One
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- (2014) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
- (2014) Helen M Colhoun et al. BMC Cardiovascular Disorders
- Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
- (2014) John J. P. Kastelein et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
- (2014) Jennifer G. Robinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
- (2014) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease
- (2014) L. Calabresi et al. JOURNAL OF INTERNAL MEDICINE
- HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction
- (2014) S. Zewinger et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
- (2014) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients
- (2014) G. Silbernagel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
- (2014) R. Haynes et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
- (2014) Christoph Wanner et al. KIDNEY INTERNATIONAL
- Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
- (2014) H. Moradi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Association between LDL-C and Risk of Myocardial Infarction in CKD
- (2013) M. Tonelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Proprotein convertase subtilisin/kexin type 9 inhibition
- (2012) David A. Marais et al. CURRENT OPINION IN LIPIDOLOGY
- The PCSK9 decade
- (2012) Gilles Lambert et al. JOURNAL OF LIPID RESEARCH
- Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
- (2012) Suguru Yamamoto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
- (2011) R Peto BRITISH JOURNAL OF CANCER
- Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression
- (2011) Nosratola D. Vaziri et al. Clinical and Experimental Nephrology
- Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis
- (2011) W. Marz et al. Clinical Journal of the American Society of Nephrology
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Arterial stiffness in chronic kidney disease: causes and consequences
- (2010) C. D. Chue et al. HEART
- Dyslipidemia in renal disease: Causes, consequences and treatment
- (2010) Joana Mesquita et al. Endocrinologia y Nutricion
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V
- (2008) S. Seiler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More